1 Introduction Human bone is a specialized, dynamic connective tissue characterized by high mineralization and vascularization
A., Mignion, L., Desmet, C., Gourgue, F., Jonas, J
Experimental evidence is ongoing to explore and unravel all these possible beneficial mechanisms, while the combination of both drug categories (at least in patients with T2D) with or without other therapeutic strategies seems promising
Mechanism: Why these drugs work (and why they cause problems) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were initially approved in 2005 for the treatment of type 2 diabetes
What makes ESN L-Carnitine unique